263 related articles for article (PubMed ID: 32345219)
21. Avoidable Burden of Cardiovascular Diseases in the Eastern Mediterranean Region: Contribution of Selected Risk Factors for Cardiovascular-Related Deaths.
Mazloumi E; Poorolajal J; Sarrafzadegan N; Roohafza HR; Faradmal J; Karami M
High Blood Press Cardiovasc Prev; 2019 Jun; 26(3):227-237. PubMed ID: 31228169
[TBL] [Abstract][Full Text] [Related]
22. The impact of multiple interventions to reduce household exposure to second-hand tobacco smoke among women: a cluster randomized controlled trial in Kalutara district, Sri Lanka.
Alagiyawanna AMAAP; Rajapaksa-Hewageegana N; Gunawardena N
BMC Public Health; 2017 Oct; 17(1):810. PubMed ID: 29037230
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States.
Lu Y; Wang P; Zhou T; Lu J; Spatz ES; Nasir K; Jiang L; Krumholz HM
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374046
[TBL] [Abstract][Full Text] [Related]
24. Long-term effects on cardiovascular risk of a structured multidisciplinary lifestyle program in clinical practice.
Lidin M; Hellénius ML; Rydell-Karlsson M; Ekblom-Bak E
BMC Cardiovasc Disord; 2018 Apr; 18(1):59. PubMed ID: 29609555
[TBL] [Abstract][Full Text] [Related]
25. Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign.
Omboni S; Carabelli G; Ghirardi E; Carugo S
Vasc Health Risk Manag; 2013; 9():177-85. PubMed ID: 23662063
[TBL] [Abstract][Full Text] [Related]
26. Good glycemic control of gestational diabetes mellitus is associated with the attenuation of future maternal cardiovascular risk: a retrospective cohort study.
Yefet E; Schwartz N; Sliman B; Ishay A; Nachum Z
Cardiovasc Diabetol; 2019 Jun; 18(1):75. PubMed ID: 31167664
[TBL] [Abstract][Full Text] [Related]
27. The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus.
Dutton GR; Lewis CE
Prog Cardiovasc Dis; 2015; 58(1):69-75. PubMed ID: 25936906
[TBL] [Abstract][Full Text] [Related]
28. Twenty-year trends in cardiovascular risk factors in India and influence of educational status.
Gupta R; Guptha S; Gupta VP; Agrawal A; Gaur K; Deedwania PC
Eur J Prev Cardiol; 2012 Dec; 19(6):1258-71. PubMed ID: 21947630
[TBL] [Abstract][Full Text] [Related]
29. Lifestyle factors associated with obesity in a cohort of males in the central province of Sri Lanka: a cross-sectional descriptive study.
Jayawardana NW; Jayalath WA; Madhujith WM; Ralapanawa U; Jayasekera RS; Alagiyawanna SA; Bandara AM; Kalupahana NS
BMC Public Health; 2017 Jan; 17(1):27. PubMed ID: 28056898
[TBL] [Abstract][Full Text] [Related]
30. Clustering of cardiovascular risk factors in semi-urban communities in south-western Nigeria.
Oluyombo R; Akinwusi PO; Olamoyegun MO; Ayodele OE; Fawale MB; Okunola OO; Olanrewaju TO; Akinsola A
Cardiovasc J Afr; 2016 Sep/Oct 23; 27(5):322-327. PubMed ID: 27284905
[TBL] [Abstract][Full Text] [Related]
31. The prevalence, predictors and associations of hypertension in Sri Lanka: a cross-sectional population based national survey.
Katulanda P; Ranasinghe P; Jayawardena R; Constantine GR; Rezvi Sheriff MH; Matthews DR
Clin Exp Hypertens; 2014; 36(7):484-91. PubMed ID: 24433043
[TBL] [Abstract][Full Text] [Related]
32. A cross-sectional study on peripheral arterial disease in a district of Sri Lanka: prevalence and associated factors.
Weragoda J; Seneviratne R; Weerasinghe MC; Wijeyaratne M; Samaranayaka A
BMC Public Health; 2015 Aug; 15():829. PubMed ID: 26316186
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of cardiovascular diseases and risk factors in adult patients with haemophilia: a cross-sectional study in a tertiary care hospital clinic in Sri Lanka.
Vithanage T; Ratnamalala V; Wickramaratne C; Katulanda G; Rodrigo CH
BMC Cardiovasc Disord; 2022 Jul; 22(1):343. PubMed ID: 35907807
[TBL] [Abstract][Full Text] [Related]
34. Comparison of trends in cardiovascular risk factors between two regions with and without a community and primary care prevention programme.
Eliasson M; Eriksson M; Lundqvist R; Wennberg P; Söderberg S
Eur J Prev Cardiol; 2018 Nov; 25(16):1765-1772. PubMed ID: 29846119
[TBL] [Abstract][Full Text] [Related]
35. Clinical implications of the metabolic syndrome.
Ceska R
Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S2-4. PubMed ID: 17935057
[TBL] [Abstract][Full Text] [Related]
36. Analysis of incidence and prevalence of cardiovascular risk factors and evaluation of their control in epidemiological survey in the Czech Republic.
Chmelík Z; Vaclová M; Lánská V; Laštůvka J; Vrablík M
Cent Eur J Public Health; 2020 Jun; 28(2):114-119. PubMed ID: 32592555
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH
J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689
[TBL] [Abstract][Full Text] [Related]
38. The effect of youths as change agents on cardiovascular disease risk factors among adult neighbours: a cluster randomised controlled trial in Sri Lanka.
Chandraratne N; Yamaguchi M; Indrawansa S; Gunawardena N; Kuwahara K; Islam Z; Kawasaki Y; Mizoue T; Samarasinghe D
BMC Public Health; 2019 Jul; 19(1):893. PubMed ID: 31286931
[TBL] [Abstract][Full Text] [Related]
39. Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study.
Alzubaidi HT; Chandir S; Hasan S; McNamara K; Cox R; Krass I
BMJ Open; 2019 Nov; 9(11):e031246. PubMed ID: 31712336
[TBL] [Abstract][Full Text] [Related]
40. Absolute cardiovascular risk in a Fiji medical zone.
Gyaneshwar R; Naidu S; Raban MZ; Naidu S; Linhart C; Morrell S; Tukana I; Taylor R
BMC Public Health; 2016 Feb; 16():128. PubMed ID: 26861211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]